13301甲第4673号博士（医学）金沢大学博士論文本文Full 以下に掲載：cancer science 109(3) pp.724-731 2018. Wiley. 共著者：Satoko Urata, Kouji Izumi, Kaoru Hiratsuka, Aerken Maolake, Ariunbold Natsagdorj, Kazuyoshi Shigehara, Hiroaki Iwamoto, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Yoshifumi Kadono, Wen‐Jye Lin, Guzailinuer Wufuer, Kazutaka Narimoto, Atsushi Mizokam
CXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful attracta...
BACKGROUND: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previo...
AbstractCXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful ...
13301甲第4673号博士（医学）金沢大学博士論文要旨Abstract 以下に掲載：cancer science 109(3) pp.724-731 2018. Wiley. 共著者：Satoko ...
[[abstract]]Chemokines and their receptors have key roles in cancer progression. This study investig...
[[abstract]]BACKGROUND: Chemokine ligand 2 (CCL2), also known as monocyte chemoattractant protein-1 ...
Prostate cancer (PCa) is considered as the most common cancer of urologic neoplasms, and its develop...
AbstractTumor cells in the bone interact with the microenvironment to promote tumor cell survival an...
Src family kinases (SFK) integrate signal transduction for multiple receptors, regulating cellular p...
Nearly 85% of the men who will die of prostate cancer (PCa) have skeletal metastases present. The ab...
Src family kinases (SFK) integrate signal transduction for multiple receptors, regulating cellular p...
Src family kinases (SFK) integrate signal transduction for multiple receptors, regulating cellular p...
13301甲第4515号博士（医学）金沢大学博士論文本文Full 以下に掲載：Oncotarget 8(6) pp.9739-9751 2017. Oncotarget. 共著者：Aerken Mao...
CC chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein-1) has been demonstrated...
Androgen/androgen receptor (AR) signaling is a significant driver of prostate cancer progression, th...
CXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful attracta...
BACKGROUND: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previo...
AbstractCXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful ...
13301甲第4673号博士（医学）金沢大学博士論文要旨Abstract 以下に掲載：cancer science 109(3) pp.724-731 2018. Wiley. 共著者：Satoko ...
[[abstract]]Chemokines and their receptors have key roles in cancer progression. This study investig...
[[abstract]]BACKGROUND: Chemokine ligand 2 (CCL2), also known as monocyte chemoattractant protein-1 ...
Prostate cancer (PCa) is considered as the most common cancer of urologic neoplasms, and its develop...
AbstractTumor cells in the bone interact with the microenvironment to promote tumor cell survival an...
Src family kinases (SFK) integrate signal transduction for multiple receptors, regulating cellular p...
Nearly 85% of the men who will die of prostate cancer (PCa) have skeletal metastases present. The ab...
Src family kinases (SFK) integrate signal transduction for multiple receptors, regulating cellular p...
Src family kinases (SFK) integrate signal transduction for multiple receptors, regulating cellular p...
13301甲第4515号博士（医学）金沢大学博士論文本文Full 以下に掲載：Oncotarget 8(6) pp.9739-9751 2017. Oncotarget. 共著者：Aerken Mao...
CC chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein-1) has been demonstrated...
Androgen/androgen receptor (AR) signaling is a significant driver of prostate cancer progression, th...
CXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful attracta...
BACKGROUND: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previo...
AbstractCXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful ...
DOI
Add to ORKG